Literature DB >> 6312790

Alpha-receptor restriction of coronary blood flow during atrial fibrillation.

J Wichmann, G Ertl, W Höhne, H Schweisfurth, H Wernze, K Kochsiek.   

Abstract

The effects of atrial fibrillation (AF) on coronary circulation before and after alpha-receptor blockade were studied in 14 anesthetized, open-chest dogs. AF was induced by electrical stimulation of the left atrial appendage; identical rhythmic heart rates were adjusted by left atrial pacing. During atrial pacing, coronary vascular resistance (CVR) was 0.97 +/- 0.10 mm Hg X min X 100 g/ml (resistance units [RU]), coronary blood flow (CBF) 125 +/- 14 ml/min X 100 g, and oxygen saturation 30 +/- 2%; plasma epinephrine was 193 +/- 42 pg/ml and norepinephrine 584 +/- 111 pg/ml. During AF, CVR was higher (1.16 +/- 0.11 RU, p less than 0.0005), whereas CBF (92 +/- 9 ml/min X 100 g, p less than 0.001) and coronary sinus oxygen saturation (24 +/- 2%, p less than 0.0025) were lower than during atrial pacing. When AF was induced, epinephrine increased to 333 +/- 98 pg/ml (p less than 0.05) and norepinephrine to 1,005 +/- 214 pg/ml (p less than 0.005). The large increase in plasma catecholamines suggested an activation of the sympathoadrenal system during AF. In addition, the alpha-receptor blocker phenoxybenzamine (10 mg/kg, intravenously) abolished the differences in CVR, CBF and oxygen saturation between AF and atrial pacing. The data suggest that the decrease in CBF and increase in CVR during experimentally induced AF are caused by coronary vasoconstriction, mediated by sympathetic activation of alpha receptors in the coronary vascular bed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312790     DOI: 10.1016/0002-9149(83)90435-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Alterations in atrial perfusion during atrial fibrillation.

Authors:  Christina F Pacchia; Derek J Dosdall; Ravi Ranjan; Edward DiBella
Journal:  Exp Physiol       Date:  2014-07-25       Impact factor: 2.969

2.  Alpha-receptor constriction induced by atrial fibrillation during maximal coronary dilatation.

Authors:  G Ertl; J Wichmann; M Kaufmann; K Kochsiek
Journal:  Basic Res Cardiol       Date:  1986 Jan-Feb       Impact factor: 17.165

3.  Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial.

Authors:  T J Campbell; T P Gavaghan; J J Morgan
Journal:  Br Heart J       Date:  1985-07

Review 4.  Pharmacological mechanisms to attenuate sympathetically induced myocardial ischemia.

Authors:  R Schulz; B D Guth; G Heusch
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

5.  Reduction of myocardial infarct size by dronedarone in pigs--a pleiotropic action?

Authors:  Andreas Skyschally; Gerd Heusch
Journal:  Cardiovasc Drugs Ther       Date:  2011-06       Impact factor: 3.727

Review 6.  The current approach of atrial fibrillation management.

Authors:  Anish Amin; Aseel Houmsse; Abiodun Ishola; Jaret Tyler; Mahmoud Houmsse
Journal:  Avicenna J Med       Date:  2016 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.